KUB Technologies, Inc. – Trademark Portfolio
Entity Type: 03
KUB Technologies, Inc. holds 39 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 20 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 17 trademarks are registered and 6 are pending. Notable registered marks include XCELL, XSEED, KUBTEC, MOZART, and DIGICOM. The owner is based in STRATFORD, CT.
111 RESEARCH DRIVE
STRATFORD, CT 06615
Showing of trademarks Trademarks
Trademark Classifications
KUB Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does KUB Technologies, Inc. have?
KUB Technologies, Inc. has 39 U.S. trademarks filed with the USPTO. Of these, 17 registered, 6 pending, 10 abandoned, 6 cancelled.
What trademark classes does KUB Technologies, Inc. file in?
KUB Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are KUB Technologies, Inc.'s most well-known trademarks?
KUB Technologies, Inc.'s registered trademark portfolio includes well-known marks such as XCELL, XSEED, KUBTEC, MOZART, and DIGICOM. These are among 17 currently registered trademarks in the portfolio.
What is KUB Technologies, Inc.'s trademark registration success rate?
KUB Technologies, Inc. has a 52% trademark registration rate, with 17 out of 33 resolved applications resulting in successful registration. Currently, 6 applications are pending review.